tiprankstipranks
Trending News
More News >
Oncotelic Therapeutics Inc (OTLC)
:OTLC
US Market
Advertisement

Oncotelic Therapeutics (OTLC) Income Statement

Compare
82 Followers

Oncotelic Therapeutics Income Statement

Last quarter (Q1 2025), Oncotelic Therapeutics's total revenue was $0.00, a decrease of ― from the same quarter last year. In Q1, Oncotelic Therapeutics's net income was $-298.72K. See Oncotelic Therapeutics’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 24Dec 23Dec 22Dec 21Dec 20
Total Revenue
$ 0.00$ 70.00K$ 0.00$ 0.00$ 1.74M
Gross Profit
$ 0.00$ 70.00K$ -12.84K$ -61.51K$ 1.74M
Operating Expenses
$ 376.01K$ 6.72M$ 5.61M$ 9.13M$ 9.33M
Depreciation and Amortization
$ 1.81B$ 12.84K$ 12.84K$ 61.51K$ 364.21K
EBITDA
$ -3.58B$ -7.16M$ -5.60M$ -9.06M$ -7.61M
Operating Income
$ -3.58B$ -6.65M$ -9.72M$ -9.13M$ -7.58M
Other Income/Expenses
$ -947.92M$ -1.56M$ 14.40M$ -1.39M$ -2.39M
Pretax Income
$ -4.52B$ -8.21M$ 4.68M$ -10.52M$ -9.97M
Net Income
$ -4.52B$ -7.90M$ 17.82M$ -11.39M$ -11.50M
Per Share Metrics
Basic EPS
$ -0.01$ -0.02$ 0.05$ -0.04$ -0.13
Diluted EPS
$ -0.01$ -0.02$ 0.04$ -0.04$ -0.13
Weighted Average Shares Outstanding
404.40M 396.17M 384.08M 303.08M 88.10M
Weighted Average Shares Outstanding (Diluted)
404.40M 396.17M 457.30M 303.08M 88.10M
Currency in USD

Oncotelic Therapeutics Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis